Your browser doesn't support javascript.
loading
Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1.
Chen, Yiyan; Li, Min; Yang, Yanying; Lu, Yan; Li, Xiaoying.
Affiliation
  • Chen Y; Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li M; Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China; The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
  • Yang Y; Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lu Y; Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China; Institute of Metabolism and Regenerative Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong Universit
  • Li X; Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University,
J Biol Chem ; 298(12): 102678, 2022 12.
Article in En | MEDLINE | ID: mdl-36356901

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metformin Limits: Humans Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country: China Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metformin Limits: Humans Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country: China Country of publication: United States